螨性哮喘特异性免疫治疗机制研究进展

被引:7
作者
张超
姜玉新
李朝品
机构
[1] 皖南医学院人体寄生虫学教研室
基金
安徽省自然科学基金;
关键词
尘螨; 哮喘; 变应原特异性免疫治疗; 机制; 综述;
D O I
10.13350/j.cjpb.2010.04.021
中图分类号
R562.25 [];
学科分类号
摘要
近30年来支气管哮喘的患病率呈明显上升趋势。变应原是哮喘重要的诱发因素,尘螨是过敏性哮喘最常见的变应原之一。变应原特异性免疫治疗是目前过敏性哮喘唯一的病因预防及治疗方法。本文就螨性哮喘特异性免疫治疗机制研究现状进行概述。
引用
收藏
页码:313 / 316
页数:4
相关论文
共 13 条
[1]
粉螨性哮喘发病机制研究进展 [J].
朱万春 ;
诸葛洪祥 .
环境与健康杂志, 2007, (03) :184-186
[2]
螨性哮喘患者脱敏治疗前后免疫功能的变化 [J].
李朝品 ;
崔玉宝 ;
杨庆贵 .
安徽大学学报(自然科学版), 2003, (02) :104-107
[3]
CD8<sup>+</sup>γδ T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen.[J].Juan Zhou;Sarah E. Appleton;Andrew Stadnyk;Timothy D. G. Lee;Bjorn A. P. Nashan.Transplant International.2008, 7
[4]
Regulatory T cells and immune tolerance [J].
Sakaguchi, Shimon ;
Yamaguchi, Tomoyuki ;
Nomura, Takashi ;
Ono, Masahiro .
CELL, 2008, 133 (05) :775-787
[5]
Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa [J].
Radulovic, Suzana ;
Jacobson, Mikila R. ;
Durham, Stephen R. ;
Nouri-Aria, Kayhan T. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) :1467-1472
[6]
Recombinant allergens for immunotherapy [J].
Valenta, Rudolf ;
Niederberger, Verena .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (04) :826-830
[7]
Healthy immune response to allergens: T regulatory cells and more [J].
Akdis, Muebeccel .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (06) :738-744
[8]
Role of regulatory T cells in human diseases [J].
Chatila, TA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) :949-959
[9]
Interleukin-17 family members and inflammation [J].
Kolls, JK ;
Lindén, A .
IMMUNITY, 2004, 21 (04) :467-476
[10]
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease [J].
Ling, EM ;
Smith, T ;
Nguyen, XD ;
Pridgeon, C ;
Dallman, M ;
Arbery, J ;
Carr, VA ;
Robinson, DS .
LANCET, 2004, 363 (9409) :608-615